Loxo Oncology, Inc
LOXO
LOXO was delisted on the 14th of February, 2019.
42 hedge funds and large institutions have $150M invested in Loxo Oncology, Inc in 2014 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 16 increasing their positions, 7 reducing their positions, and 3 closing their positions.
300% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 3
129% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 7
20% more funds holding
Funds holding: 35 → 42 (+7)
2% more capital invested
Capital invested by funds: $147M → $150M (+$3.47M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NMC
NEA Management Company
Timonium,
Maryland
|
+$20.9M |
| 2 |
RIM
RS Investment Management
San Francisco,
California
|
+$1.57M |
| 3 |
VAM
Visium Asset Management
New York
|
+$786K |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$434K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$416K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RG
Redmile Group
San Francisco,
California
|
-$4.69M |
| 2 |
Jennison Associates
New York
|
-$1.64M |
| 3 |
Millennium Management
New York
|
-$750K |
| 4 |
SIM
Spark Investment Management
New York
|
-$199K |
| 5 |
NIP
Nicholas Investment Partners
Rancho Santa Fe,
California
|
-$150K |
LOXO Hedge Fund Activity: Q4 2014 in Review
42 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Loxo Oncology, Inc (LOXO) for Q4 2014, worth a combined $150M — up 2.4% from $147M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new LOXO positions and 3 closed out — a net gain of 9 holders — while 16 added to existing stakes and 7 trimmed.
The largest buyer was NEA Management Company, opening a new position worth an estimated $20.9M. The largest seller was Redmile Group, cutting an estimated $4.69M.
- 42 institutional investors held Loxo Oncology, Inc (LOXO) as of Q4 2014, up from 35 in Q3 2014.
- Funds reported $150M of Loxo Oncology, Inc stock for Q4 2014, up 2.4% quarter-over-quarter.
- 12 funds opened new Loxo Oncology, Inc positions in Q4 2014 and 3 closed out, a net change of +9 holders.
- The largest Loxo Oncology, Inc buyer in Q4 2014 was NEA Management Company, an estimated $20.9M added.
- The largest Loxo Oncology, Inc seller in Q4 2014 was Redmile Group, an estimated $4.69M sold.
Based on aggregated 13F filings for Q4 2014.